Quantedge Capital Pte LTD Catalyst Pharmaceuticals, Inc. Transaction History

Quantedge Capital Pte LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$14.34 - $21.05 $434,502 - $637,815	-30,300 Reduced 8.54%	324,700 $5.38 Million
Q4 2022 Feb 14, 2023	SELL	$12.25 - $19.5 $1.82 Million - $2.9 Million	-148,700 Reduced 29.52%	355,000 $6.6 Million
Q3 2022 Nov 10, 2022	SELL	$7.06 - $15.52 $1.16 Million - $2.55 Million	-164,200 Reduced 24.58%	503,700 $6.46 Million
Q2 2022 Aug 12, 2022	BUY	$6.23 - $8.57 $439,838 - $605,042	70,600 Added 11.82%	667,900 $4.68 Million
Q1 2022 May 13, 2022	BUY	$5.31 - $8.31 $1.26 Million - $1.97 Million	237,200 Added 65.87%	597,300 $4.95 Million
Q4 2021 Feb 11, 2022	BUY	$5.21 - $7.45 $1.88 Million - $2.68 Million	360,100 New	360,100 $2.44 Million

327

94.1M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.33B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Quantedge Capital Pte LTD, based on Form 13F filings with the SEC.

Stay updated on Quantedge Capital Pte LTD with notifications on news.